AbbVie (ABBV) Long-Term Investments (2012 - 2026)
AbbVie (ABBV) reported Long-Term Investments of $266 million for Q2 2026, down 14.2% from $310 million a year earlier and down 0.7% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Long-Term Investments (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie posted Long-Term Investments of $268 million, down 3.9% from FY2024.
- Long-Term Investments has a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- By year, Long-Term Investments came in at $279 million in FY2024 (-8.2%), $304 million in FY2023 (+26.1%), $241 million in FY2022 (-13.0%) and $277 million in FY2021 (-5.5%).
- The Q2 2026 figure ranks as the lowest quarterly Long-Term Investments since Q1 2023.
- Year over year, Long-Term Investments has now declined in each of the last three quarters, with an average decline of 2.4% over the last eight quarters.
- The high point for year-over-year Long-Term Investments in five years was Q4 2023 (growth of 26.1%); the low point was Q1 2022 (a decline of 14.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $268 million (Q1 2026), $268 million (Q4 2025) and $291 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,263.50 Bn | 1,237.12 Bn | 20.46 Bn | 4.01 Bn |
| 2 | Johnson & Johnson | 655.05 Bn | 574.91 Bn | 17.30 Bn | - |
| 3 | AbbVie | 512.00 Bn | 485.11 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 368.57 Bn | 368.57 Bn | - | - |
| 5 | Novartis Ag | 313.61 Bn | 286.85 Bn | - | 63.00 Mn |
| 6 | Astrazeneca | 290.22 Bn | 263.91 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 252.64 Bn | 208.04 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 212.62 Bn | 212.62 Bn | - | - |
| 9 | Pfizer | 175.96 Bn | 122.60 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Vertex Pharmaceuticals | 140.19 Bn | 112.20 Bn | 2.84 Bn | 5.79 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 266.00 Mn |
| Mar 31, 2026 | 268.00 Mn |
| Dec 31, 2025 | 268.00 Mn |
| Sep 30, 2025 | 291.00 Mn |
| Jun 30, 2025 | 310.00 Mn |
| Mar 31, 2025 | 287.00 Mn |
| Dec 31, 2024 | 279.00 Mn |
| Sep 30, 2024 | 267.00 Mn |
| Jun 30, 2024 | 272.00 Mn |
| Mar 31, 2024 | 305.00 Mn |
| Dec 31, 2023 | 304.00 Mn |
| Sep 30, 2023 | 275.00 Mn |
| Jun 30, 2023 | 288.00 Mn |
| Mar 31, 2023 | 257.00 Mn |
| Dec 31, 2022 | 241.00 Mn |
| Sep 30, 2022 | 235.00 Mn |
| Jun 30, 2022 | 244.00 Mn |
| Mar 31, 2022 | 260.00 Mn |
| Dec 31, 2021 | 277.00 Mn |
| Sep 30, 2021 | 272.00 Mn |
API Access
AbbVie Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();